Stress associated gene expression in blood cells is related to outcome in radiotherapy treated head and neck cancer patients
Creators
- 1. Department of Nutrition, Institute of Basic Medical Sciences, University of Oslo, Oslo, 0316 (Norway)
- 2. Division of Cancer, Surgery and Transplantation, Oslo University Hospital, Oslo, 0310 (Norway)
- 3. Department of Biostatistics, Institute of Basic Medical Sciences, University of Oslo, Oslo, 0316 (Norway)
- 4. Norwegian Computing Center, Oslo, 0314 (Norway)
- 5. Department of Biochemistry, Institute of Basic Medical Sciences, University of Oslo, Oslo, 0316 (Norway)
- 6. Department of Clinical Chemistry, Oslo University Hospital, Ullevål, Oslo, 0407 (Norway)
- 7. Institute for Clinical Medicine, University of Oslo, Oslo, 0316 (Norway)
Description
We previously observed that a radiotherapy-induced biochemical response in plasma was associated with favourable outcome in head and neck squamous carcinoma cancer (HNSCC) patients. The aim of the present study was to compare stress associated blood cell gene expression between two sub-groups of HNSCC patients with different biochemical responses to radiotherapy. Out of 87 patients (histologically verified), 10 biochemical 'responders' having a high relative increase in plasma oxidative damage and a concomitant decrease in plasma antioxidants during radiotherapy and 10 'poor-responders' were selected for gene-expression analysis and compared using gene set enrichment analysis. There was a significant induction of stress-relevant gene-sets in the responders following radiotherapy compared to the poor-responders. The relevance of the involvement of similar stress associated gene expression for HNSCC cancer and radioresistance was verified using two publicly available data sets of 42 HNSCC cases and 14 controls (GEO GSE6791), and radiation resistant and radiation sensitive HNSCC xenografts (E-GEOD-9716). Radiotherapy induces a systemic stress response, as revealed by induction of stress relevant gene expression in blood cells, which is associated to favourable outcome in a cohort of 87 HNSCC patients. Whether these changes in gene expression reflects a systemic effect or are biomarkers of the tumour micro-environmental status needs further study. Raw data are available at ArrayExpress under accession number E-MEXP-2460
Availability note (English)
Available from http://dx.doi.org/10.1186/1471-2407-12-426; Available from http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3517770Additional details
Identifiers
Publishing Information
- Journal Title
- BMC cancer (Online)
- Journal Volume
- 12
- Journal Page Range
- p. 426
- ISSN
- 1471-2407
INIS
- Country of Publication
- United Kingdom
- Country of Input or Organization
- International Atomic Energy Agency (IAEA)
- INIS RN
- 46111797
- Subject category
- S62: RADIOLOGY AND NUCLEAR MEDICINE;
- Descriptors DEI
- ANTIOXIDANTS; BLOOD CELLS; CARCINOMAS; DAMAGE; GENES; HEAD; NECK; NEOPLASMS; PATIENTS; RADIOSENSITIVITY; RADIOTHERAPY
- Descriptors DEC
- BIOLOGICAL MATERIALS; BLOOD; BODY; BODY FLUIDS; DISEASES; MATERIALS; MEDICINE; NEOPLASMS; NUCLEAR MEDICINE; RADIOLOGY; SENSITIVITY; THERAPY
Optional Information
- Copyright
- Copyright (c)2012 B#Latin Small Letter O With Stroke#hn et al.
- Notes
- PMCID: PMC3517770; PUBLISHER-ID: 1471-2407-12-426; PMID: 23009663; OAI: oai:pubmedcentral.nih.gov:3517770; licensee BioMed Central Ltd.